2Li X, Yang HY, Giachelli CM. BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle ceils. Atherosclerosis, 2008,199 : 271 - 277.
3Mizobuehi M, Ogata H, Hatamura I, et al. Up-regulation of Cbfal and Pit-1 in calcified artery of uraemic rats with severe hyperphosphataemia and secondary hyperparathyroidism. Nephrol Dial Transplant, 2006 ,21:911-916.
4Ballanti P, Silvestrini G, Pisano S, et al. Medial artery calcification of uremic patients: a histological, histochemical and ultrastructural study. Histol Histopatho1,2011,26 : 191-200.
5Lau WL, Pal A, Moe SM, et al. Direct effects of phosphate on vascular cell function. Adv Chronic Kidney Dis, 2011,18 : 105- 112.
6Zavaczki E, Jeney V, Agarwal A, et al. Hydrogen sulfide inhibits the calcification and osteoblastic differentiation of vascular smooth muscle ceils. Kidney Int,2011,80:731-739.
7Du Y, Wang Y, Wang L, et al. Cartilage oligomeric matrix protein inhibits vascular smooth muscle calcification by interacting with bone morphogenetic protein-2. Circ Res, 2011,108: 917- 928.
3K/DOQI. Clinical practice guide lines for cardiovascular disease in dialysis patients. Am J Kidney Dis,2005,45 : s1153.
4Eknoyan G, Levin A,Levin NW, et al. Bone metabolism and dis- ease in chronic kidney disease. Am J Kidney Dis, 2003,42 (2): 197-201.
5Coodman WG, Coldin J, Kuion BD, et al. Coronary artery calcifi- cation in young adults with end stage renal disease who are un- dergoing dialysis. New Engl Med, 2002,342 (20), : 1478-1483.
6Block GA, Hulbert-Shearon TE, Levin NW et al. Association of serum phosphorus and calcium. Phosphorus product with mortal- ity risk in chronic hemodialysis is patients: A national study. Am J Kidney Dis, 1998,31 (4) :607- 617.
7Macdougall IC, Tucker B, Thompson J, et al. A randomized controlled study of iron supplementation in patients treated with erythropoietin. Kid Int. 1996, 50: 1694.
8Collins AJ, Kasiske B, Herzog C, et al. United States renal data system 2006 annual data report. Am J Kidney Dis, 2007,49: s1- s296.
9Rayner HC, Besarab A, Brown WW, et al. Vascular access re- suits from the Dialysis Outcomes and Practice Patterns Study (DOPPS): performance against Kidney Disease Outcomes Quali- ty Initiative (K/DOQI) Clinical Practice Guidelines. Am J Kid ney Dis, 2004, 44(5 Suppl 2) :22-26.
10Patel PR, Thompson ND, Kallen AJ, et al. Epidemiology, sur veillance, and prevention of hepatitis C virus infections in hemo- dialysis patients. Am J Kidney Dis, 2010,56:371-378.
